NasdaqGM - Nasdaq Real Time Price USD

Burning Rock Biotech Limited (BNR)

Compare
7.02
-0.30
(-4.10%)
At close: January 10 at 4:00:00 PM EST
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
510,885.00
537,435.00
563,238.00
507,862.00
429,903.00
Cost of Revenue
159,794.00
174,208.00
183,199.00
143,716.00
115,981.00
Gross Profit
351,091.00
363,227.00
380,039.00
364,146.00
313,922.00
Operating Expense
793,047.00
1,032,548.00
1,360,446.00
1,161,210.00
726,327.00
Operating Income
-441,956.00
-669,321.00
-980,407.00
-797,064.00
-412,405.00
Net Non Operating Interest Income Expense
15,937.00
17,956.00
9,458.00
1,921.00
5,401.00
Other Income Expense
116.00
64.00
1,701.00
-655.00
-231.00
Pretax Income
-425,903.00
-651,301.00
-969,248.00
-795,798.00
-407,235.00
Tax Provision
1,642.00
2,388.00
1,985.00
899.00
--
Net Income Common Stockholders
-427,545.00
-653,689.00
-971,233.00
-796,697.00
-471,923.00
Diluted NI Available to Com Stockholders
-427,545.00
-653,689.00
-971,233.00
-796,697.00
-471,923.00
Basic EPS
-41.60
-63.80
-93.50
-76.50
-68.80
Diluted EPS
-41.60
-63.80
-93.50
-76.50
-68.80
Basic Average Shares
10,269.37
10,239.65
10,390.90
10,420.79
6,863.45
Diluted Average Shares
10,269.37
10,239.65
10,390.90
10,420.79
6,863.45
Total Operating Income as Reported
-441,956.00
-669,321.00
-980,407.00
-797,064.00
-412,405.00
Total Expenses
952,841.00
1,206,756.00
1,543,645.00
1,304,926.00
842,308.00
Net Income from Continuing & Discontinued Operation
-427,545.00
-653,689.00
-971,233.00
-796,697.00
-407,235.00
Normalized Income
-427,247.25
-653,374.00
-972,394.75
-796,056.50
-407,891.00
Interest Income
15,937.00
17,956.00
9,458.00
3,457.00
6,068.00
Interest Expense
--
--
--
1,536.00
667.00
Net Interest Income
15,937.00
17,956.00
9,458.00
1,921.00
5,401.00
EBIT
-423,936.00
-651,301.00
-980,407.00
-794,262.00
-406,568.00
EBITDA
-423,936.00
-517,901.00
-856,311.00
-746,496.00
-373,259.00
Reconciled Cost of Revenue
159,794.00
174,208.00
183,199.00
143,716.00
115,981.00
Reconciled Depreciation
--
133,400.00
124,096.00
47,766.00
33,309.00
Net Income from Continuing Operation Net Minority Interest
-427,545.00
-653,689.00
-971,233.00
-796,697.00
-407,235.00
Total Unusual Items Excluding Goodwill
-397.00
-420.00
1,549.00
-854.00
656.00
Total Unusual Items
-397.00
-420.00
1,549.00
-854.00
656.00
Normalized EBITDA
-423,539.00
-517,481.00
-857,860.00
-745,642.00
-373,915.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-99.25
-105.00
387.25
-213.50
--
12/31/2020 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PMDI Psychemedics Corporation
2.1400
-0.47%
 
XGN Exagen Inc.
3.1700
-3.65%
 
BDSX Biodesix, Inc.
1.2700
-14.19%
 
CDNA CareDx, Inc
23.63
-1.54%
 
ISPC iSpecimen Inc.
2.6800
-6.62%
 
PSNL Personalis, Inc.
5.59
-0.18%
 
EXAS Exact Sciences Corporation
56.50
-0.32%
 
GRAL GRAIL, Inc.
17.73
+0.40%
 
VCYT Veracyte, Inc.
41.54
-5.12%
 
CSTL Castle Biosciences, Inc.
30.25
-7.55%